Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2023-04-17 00:00:00 ET · period of report 2023-04-13 · accession 0001171843-23-002340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-17 | 2023-04-13 | ANIK | Fischetti Gary P | Dir | A - Grant | $0.00 | +12.9K | 15.2K | +554% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-13 | A | A | 12,858 | $0.00 | 15,178 | D | — | — | (F1) These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning on April 13, 2024. |